Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
PT
Palatin Technologies, Inc. Common Stock
PTN
Mkt Cap
$10.7M
Volume
39.09K
Next Earnings
November 13th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
PT
PTN
PT
Palatin Technologies, Inc. Common Stock
PTN
News
·
Why Are Palatin Technologies (PTN) Shares Spiking After-Hours?
Mkt Cap
$10.7M
Volume
39.09K
Next Earnings
November 13th
Chart
Financials
Earnings
News
About
Insider
Filings
Why Are Palatin Technologies (PTN) Shares Spiking After-Hours?
Palatin Technologies saw an 8.41% after-hours stock price increase following a Janus Henderson Group 13G filing revealing a 9.99% ownership stake in the company.
Benzinga · Dec 11, 2025
Palatin Presents Breakthrough Symptom Resolution Data from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease at ARVO 2025
Palatin Technologies presented positive data from its Phase 3 MELODY-1 clinical trial of PL9643 for the treatment of dry eye disease, showing statistically significant symptom improvement and ocular surface health benefits.
Benzinga · May 8, 2025
Data la crescita esponenziale del settore del turismo in Arabia Saudita, dmg events annuncia il salone Hotel & Hospitality Expo
The 13th edition of the Hotel & Hospitality Expo Saudi Arabia will be held from April 8-10, 2025 in Riyadh. The event is expected to attract over 8,000 industry professionals and showcase the latest innovations and trends in the hospitality sector, as Saudi Arabia aims to achieve its Vision 2030 goals.
GlobeNewswire Inc. · Feb 9, 2025
As Saudi Arabia’s Tourism Sector Grows Exponentially, dmg events Announces Hotel & Hospitality Expo
The 13th edition of the Hotel & Hospitality Expo Saudi Arabia is set to return in 2025, showcasing the Kingdom's booming tourism sector and contributing to its Vision 2030 objectives. The event will feature exhibitors from 26 countries and is expected to attract 8,000 industry professionals.
GlobeNewswire Inc. · Feb 7, 2025
Palatin Technologies (PTN) Upgraded to Buy: What Does It Mean for the Stock?
Palatin Technologies (PTN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Investment Research · May 20, 2024
Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Tecogen The Trade: Tecogen Inc. (OTC: TGEN) Director John Hatsopoulos acquired a total of 1,000 shares an average price of $0.70. To acquire these shares, it cost around $700. What’s Happening: On March 13, Tecogen reported revenues of $5.9 million and a net loss of ...
Benzinga · Apr 12, 2024
Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
A late-stage study data shows that treatment with Palatin's (PTN) experimental dry eye disease drug achieved statistically significant and clinically meaningful improvements across multiple symptom endpoints.
Zacks Investment Research · Apr 9, 2024
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results. Bumble reported quarterly losses of 19 cents per share which missed the analyst consensus estimate of 12 cents per share. The company reported quarterly sales of $273.64 million which missed the analyst consensus estimate of $275.29 million. Bumble shares dipped 11.6% to $11.65 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Vivani Medical, Inc. (NASDAQ: VANI) shares jumped 289% to $3.93 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139. Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) climbed 190% to $2.4598. Adial Pharmaceuticals secured new US patent covering lead product for alcohol use disorder. vTv Therapeutics Inc. (NASDAQ: VTVT) gained 112% to $17.65 after the company announced a $51 million private placement from healthcare-focused institutional investors and the JDRF T1D Fund. Bit Brother Limited (NASDAQ: BETS) shares rose 63.7% to $4.0750. Beyond Meat, Inc. (NASDAQ: BYND) climbed 45% to $10.90 as the company reported stronger-than-expected sales for its fourth quarter. Incannex Healthcare Inc. (NASDAQ: IXHL) gained 43.6% to $6.06 after the company announced its Psi-GAD1 trial met its primary endpoint. Bandwidth Inc. (NASDAQ: BAND) surged 43.3% to $17.41 after the company reported better-than-expected fourth quarter financial results and issued FY24 revenue guidance above estimates. Imunon, Inc. (NASDAQ: IMNN) climbed 38% to $0.98. Applied Therapeutics, Inc. (NASDAQ: APLT) surged 36% to $7.59 after the company announced FDA acceptance and priority review of the NDA for govorestat for the treatment of Classic Galactosemia. The company also announced a $100 million private placement. Movella Holdings Inc. (NASDAQ: MVLA) gained 33.5% to $0.33. LifeStance Health Group, Inc. (NASDAQ: LFST) gained 31.5% to $8.81 following strong quarterly sales. AirNet Technology Inc. (NASDAQ: ANTE) rose 31.3% to $1.05. AirNet announced changes in senior management team. Polestar Automotive Holding UK PLC (NASDAQ: PSNY) rose 29.9% to $1.9350. Polestar secured $1 billion external funding. Editas Medicine, Inc. (NASDAQ: EDIT) gained 27.7% to $11.31 after the company reported better-than-expected fourth-quarter financial results. TG Therapeutics, ...
Benzinga · Feb 28, 2024
Dow Dips 200 Points; TJX Posts Upbeat Sales
U.S. stocks traded lower this morning, with the Dow Jones index falling around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.52% to 38,770.83 while the NASDAQ fell 0.63% to 15,933.71. The S&P 500 also fell, dropping, 0.33% to 5,061.21. Check This Out: Robinhood, Shake Shack And 2 Other Stocks Insiders Are Selling Leading and Lagging Sectors Energy shares rose by 0.5% on Wednesday. In trading on Wednesday, information technology shares fell by 0.8%. Top Headline The TJX Companies, Inc. (NYSE: TJX) posted better-than-expected sales for its fourth quarter on Wednesday. TJX Companies posted GAAP earnings of $1.12 per share, in-line with market estimates. The company’s quarterly sales came in at $16.40 billion, versus expectations of $16.21 billion. TJX said it sees FY25 earnings of $3.94 to $4.02 per share, versus estimates of $4.11 per share. The company expects consolidated comparable store sales gaining 2% to 3%. Equities Trading UP Vivani Medical, Inc. (NASDAQ: VANI) shares shot up 390% to $4.9478 after the company announced preclinical data on weight loss effects for NPM-115 and disclosed that semaglutide is the active pharmaceutical ingredient in NPM-139. Shares of Adial Pharmaceuticals, ...
Benzinga · Feb 28, 2024
Strength Seen in Repligen (RGEN): Can Its 4.3% Jump Turn into More Strength?
Repligen (RGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Zacks Investment Research · Jan 29, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
PT
PTN
Palatin Technologies, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
PTN
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any PTN yet.
Related Tickers
Earnings